Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/32609
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCarli, Annalisa L E-
dc.contributor.authorHardy, Joshua M-
dc.contributor.authorHoblos, Hanadi-
dc.contributor.authorErnst, Matthias-
dc.contributor.authorLucet, Isabelle S-
dc.contributor.authorBuchert, Michael-
dc.date2023-
dc.date.accessioned2023-04-14T02:47:09Z-
dc.date.available2023-04-14T02:47:09Z-
dc.date.issued2023-03-22-
dc.identifier.citationBiomedicines 2023; 11(3)en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/32609-
dc.description.abstractDoublecortin-like kinase 1 (DCLK1) is a functional serine/threonine (S/T)-kinase and a member of the doublecortin family of proteins which are characterized by their ability to bind to microtubules (MTs). DCLK1 is a proposed cancer driver gene, and its upregulation is associated with poor overall survival in several solid cancer types. However, how DCLK1 associates with MTs and how its kinase function contributes to pro-tumorigenic processes is poorly understood. This review builds on structural models to propose not only the specific functions of the domains but also attempts to predict the impact of individual somatic missense mutations on DCLK1 functions. Somatic missense mutations in DCLK1 are most frequently located within the N-terminal MT binding region and likely impact on the ability of DCLK1 to bind to αβ-tubulin and to polymerize and stabilize MTs. Moreover, the MT binding affinity of DCLK1 is negatively regulated by its auto-phosphorylation, and therefore mutations that affect kinase activity are predicted to indirectly alter MT dynamics. The emerging picture portrays DCLK1 as an MT-associated protein whose interactions with tubulin heterodimers and MTs are tightly controlled processes which, when disrupted, may confer pro-tumorigenic properties.en_US
dc.language.isoeng-
dc.subjectDCLK1en_US
dc.subjectDCXen_US
dc.subjectPEST domainen_US
dc.subjectcanceren_US
dc.subjectcryo-EMen_US
dc.subjectcrystal structureen_US
dc.subjectdoublecortin domainen_US
dc.subjectkinaseen_US
dc.subjectmicrotubulesen_US
dc.subjectmissense mutationsen_US
dc.titleStructure-Guided Prediction of the Functional Impact of DCLK1 Mutations on Tumorigenesis.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleBiomedicinesen_US
dc.identifier.affiliationOlivia Newton-John Cancer Research Instituteen_US
dc.identifier.affiliationACRF Chemical Biology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.;Department of Medical Biology, University of Melbourne, Parkville, VIC 3010, Australia.en_US
dc.identifier.affiliationSchool of Cancer Medicine, La Trobe University, Bundoora, VIC 3086, Australia.en_US
dc.identifier.doi10.3390/biomedicines11030990en_US
dc.type.contentTexten_US
dc.identifier.orcid0000-0003-0312-1097en_US
dc.identifier.orcid0000-0002-8014-8552en_US
dc.identifier.orcid0000-0002-6399-1177en_US
dc.identifier.orcid0000-0002-8563-8753en_US
dc.identifier.orcid0000-0003-2672-0148en_US
dc.identifier.pubmedid36979969-
dc.description.volume11-
dc.description.issue3-
local.name.researcherBuchert, Michael
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.openairetypeJournal Article-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

28
checked on Dec 12, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.